Flubromazolam Facts
Depressant;
Description
Flubromazolam is a synthetic depressant of the benzodiazepine class. It amplifies the brain's primary inhibitory signal — GABA — suppressing arousal, anxiety, and muscle tension throughout the central nervous system.[1]
Subjective effects include deep sedation, anxiety suppression, muscle relaxation, memory blackouts, and euphoria. The experience builds slowly over hours — a heavy, all-encompassing suppression of arousal that sets it apart from shorter-acting benzodiazepines.
Flubromazolam produces rapid physical dependence, and stopping suddenly after regular use can trigger seizures.[2] The primary danger is combination with opioids — both drugs slow breathing through overlapping pathways, and nearly all documented deaths involve this pairing.[3]
Dose and durationby route · individual sensitivity varies
Starts in 20 – 45 minLasts 10 – 18 hoursAfter-effects 12 – 48 hours
Body and dependence
- Acute toxicity
- High
- Chronic toxicity
- High
- Physical dependence
- High
- Psychological dependence
- High
- Withdrawal
- Life-threatening · fatal · medical supervision
- Compulsive redosing
- High
Tolerance
- Builds
- Rapid
- Fully resets after
- 10.5 days
- Carries over to
- benzodiazepines;
alcohol; barbiturates; z-drugs; gabapentinoids
Effectslikely at a common dose
- Perception
- Dreaming suppression;
+7 possible, including Spatial disorientation, Visual acuity suppression, Vestibular distortion - Body
- Sedation;
Motor control impairment; Muscle relaxation; Bodily heaviness; Physical fatigue; +4 possible, including Dizziness, Nystagmus (eye wobbles) - Thinking
- Thought deceleration;
Analysis suppression; Cognitive fatigue; Cognitive impairment; Decision impairment; Focus suppression; Information processing suppression; Memory suppression; +10 possible, including Delusions of sobriety, Thought disorganization, Language suppression - Feeling
- Anxiety suppression;
Emotional suppression; +3 possible, including Emotional lability - Self
- Disinhibition;
+3 possible, including Communication suppression, Craving - Time
- none likely · 2 possible, including Temporal disorientation
Who shouldn't take it
Combinations60 recorded
Seek help immediately if
- Extreme drowsiness — can't stay awake or be roused
- Confusion, slurred speech, severe loss of coordination
- Slow, shallow, or irregular breathing
- Unconsciousness / unresponsive; limp, floppy body
- Blue lips or fingertips
- Vomiting while sedated (choking / aspiration risk)
- Cold, clammy skin; weak pulse
What to do
- Try to wake them — shout, firm sternal rub
- If unresponsive or breathing is impaired, call emergency services
- Place them in the recovery position — critical, they can choke on vomit
- Monitor breathing continuously; be ready to give rescue breaths / CPR
- Never leave them alone to "sleep it off"
- Do not give other drugs, stimulants, or more depressants
Most depressant overdoses resolve with airway protection, breathing support, and monitoring. The danger is respiratory depression and choking on vomit — sharply worse when combined with opioids or alcohol. GHB/GBL overdoses often involve sudden deep unconsciousness and may self-resolve, but airway protection is essential.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Zhu S, Sridhar A, Teng J, Howard RJ, Lindahl E, Hibbs RE (2022) Structural and dynamic mechanisms of GABAA receptor modulators with opposing activities — Nature Communications doi:10.1038/s41467-022-32212-4
- [2]^Butler M, Pirkle J, Carmichael A, Carlson-Dexter P, Rosella T (2025) Successful symptom-based management of active withdrawal from multiple illicit benzodiazepines — BMJ Case Reports doi:10.1136/bcr-2025-266077
- [3]^Liu S, O'Donnell J, Gladden RM, McGlone L, Chowdhury F (2021) Trends in Nonfatal and Fatal Overdoses Involving Benzodiazepines - 38 States and the District of Columbia, 2019-2020 — MMWR Morbidity and Mortality Weekly Report doi:10.15585/mmwr.mm7034a2